Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Individual pollen exposure measurements: are they feasible?
Berger U, Kmenta M, Bastl K. Berger U, et al. Among authors: bastl k. Curr Opin Allergy Clin Immunol. 2014 Jun;14(3):200-5. doi: 10.1097/ACI.0000000000000060. Curr Opin Allergy Clin Immunol. 2014. PMID: 24739226
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper.
Pfaar O, Bastl K, Berger U, Buters J, Calderon MA, Clot B, Darsow U, Demoly P, Durham SR, Galán C, Gehrig R, Gerth van Wijk R, Jacobsen L, Klimek L, Sofiev M, Thibaudon M, Bergmann KC. Pfaar O, et al. Among authors: bastl k. Allergy. 2017 May;72(5):713-722. doi: 10.1111/all.13092. Epub 2017 Jan 27. Allergy. 2017. PMID: 27874202 Review.
Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T, Nagl B, Faustmann S, Frommlet F, Kopp S, Wolkersdorfer M, Wöhrl S, Bastl K, Huber H, Berger U, Bohle B. Kinaciyan T, et al. Among authors: bastl k. J Allergy Clin Immunol. 2018 Mar;141(3):1002-1008. doi: 10.1016/j.jaci.2017.07.036. Epub 2017 Sep 1. J Allergy Clin Immunol. 2018. PMID: 28870463 Clinical Trial.
29 results